Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
This review is focused on the inhibition of GSTs, in particular GSTP1-1, as a potential therapeutic approach for the treatment of cancer and other diseases associated with aberrant cell proliferation
These drug codes are required on the CMS-1500 claim form and must align with the documentation in the medical record
Proper dosage and medical assessment are important to avoid complications
The mechanisms of action are believed to involve glutamines role as a substrate for NO synthesis, glutathione synthesis, NAD(H), and NADP(H) synthesis (Sadaf and Quinn, 2020)
Cancerous or at risk of cancer dogs: Due to the possibility of promoting the growth of blood vessels (angiogenesis) in pets with tumors or at risk of cancer, BPC-157 may not be the best choice
